Efficacy of Rapamycin in Scleroderma: A Case Study-Reference-Cited by-同舟云学术

Efficacy of Rapamycin in Scleroderma: A Case Study

Published:2008-12 Issue:3-4 Volume:6 Page:217-219
ISSN:1539-6851
Container-title:Lymphatic Research and Biology
language:en
Short-container-title:Lymphatic Research and Biology

Author:

Fried Levi¹²,Kirsner Robert S.¹²,Bhandarkar Sulochana¹²,Arbiser Jack L.¹²

Affiliation:

1. Department of Dermatology, Emory University School of Medicine, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.

2. JLA was supported by the grant RO1 AR47901 and P30 AR42687 Emory Skin Disease Research Core Center Grant from the National Institutes of Health, a Veterans Administration Hospital Merit Award.

Publisher

Mary Ann Liebert Inc

Subject

Cardiology and Cardiovascular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/lrb.2008.1006

Reference10 articles.

1. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study

2. Animal models for scleroderma: An update

3. Absence of Cutaneous TNFα-Producing CD4+ T Cells and TNFα may Allow for Fibrosis Rather than Epithelial Cytotoxicity in Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma

4. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repurposing Patent Applications January–March 2024;ASSAY and Drug Development Technologies;2024-07-01

2. Mechanistic Target of Rapamycin Inhibition Prevents Coronary Artery Remodeling in a Murine Model of Kawasaki Disease;Arthritis & Rheumatology;2022-12-20

3. Evaluating differential expression of fibrosis-related genes and their correlation with blood vessel density in chronic cutaneous graft-versus-host disease;Journal of Dermatological Science;2022-07

4. New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy;Life;2021-06-24

5. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: from Origin to Therapeutic Targeting;Current Molecular Medicine;2021-03-25